LEUKOCYTE ADHESION DEFICIENCY TYPE II
Clinical trials for LEUKOCYTE ADHESION DEFICIENCY TYPE II explained in plain language.
Never miss a new study
Get alerted when new LEUKOCYTE ADHESION DEFICIENCY TYPE II trials appear
Sign up with your email to follow new studies for LEUKOCYTE ADHESION DEFICIENCY TYPE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for rare immune disease: new drug enters final testing
Disease control Recruiting nowThis study tests an experimental drug called AVTX-803 in people with leukocyte adhesion deficiency type II (LAD II), a rare genetic condition that weakens the immune system and leads to frequent infections. The trial will compare the drug against a period without treatment to see…
Matched conditions: LEUKOCYTE ADHESION DEFICIENCY TYPE II
Phase: PHASE3 • Sponsor: AUG Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Experimental sugar therapy tested for ultra-rare immune disorder
Disease control Recruiting nowThis phase 3 study is testing the long-term safety and effectiveness of AVTX-803, a form of L-fucose, in people with leukocyte adhesion deficiency type II (LAD II), a rare genetic disorder that weakens the immune system. Only 2 participants who completed a previous study are enro…
Matched conditions: LEUKOCYTE ADHESION DEFICIENCY TYPE II
Phase: PHASE3 • Sponsor: AUG Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC